Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Non-Resectable Cholangiocarcinoma

A cholangiocarcinoma that is not amenable to surgical resection.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Background: Cholangiocarcinoma is a malignant neoplasia that originates in the bile ducts. Most patients with cholangiocarcinoma… Expand
Review
2017
Review
2017
AIM To perform a systematic review and meta-analysis on clinical outcomes of photodynamic therapy (PDT) in non-resectable… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Review
2016
Review
2016
Background/Aims Standard treatments are not available for hilar nonresectable cholangiocarcinoma (NCC). It is unknown whether… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Review
2007
Review
2007
SUMMARY Photodynamic therapy (PDT) is a cancer treatment modality that combines the use of a photosensitizing agent and a… Expand
Review
2006
Review
2006
  • E. Rauws
  • Scandinavian journal of gastroenterology…
  • 2006
  • Corpus ID: 21087090
The prognosis of patients with an unresectable bile duct cancer is poor. In 60–70% of patients, cholangiocarcinoma is located in… Expand
Highly Cited
2005
Highly Cited
2005
Background: Photodynamic therapy (PDT) has demonstrated promise in the palliative treatment of advanced cholangiocarcinoma. The… Expand
Review
2004
Review
2004
Symptoms occur late in cholangiocarcinoma and therefore only about half of the patients at the time of diagnosis are candidates… Expand
Highly Cited
2003
Highly Cited
2003
BACKGROUND & AIMS In nonrandomized trials, photodynamic therapy (PDT) had a promising effect on nonresectable cholangiocarcinoma… Expand
Highly Cited
1996
Highly Cited
1996
BACKGROUND AND AIMS: Radiotherapy has been reported to be of benefit in prolonging the survival of patients with… Expand